Braeburn Pharmaceuticals
Braeburn is developing long-acting medicines for treating opioid addiction.
Opioid addiction, also known as opioid use disorder (OUD) is a medical condition requiring medical treatment. Together with counseling and support, Braeburn’s next generation medicines allow patients to focus on the reintegration of their lives with their families and communities. Braeburn’s long-acting injectable and implantable formulations are administered directly by healthcare professionals. Therefore, healthcare professionals are able to maximize their patient’s adherence to their prescribed treatment while minimizing the potential risks of abuse and diversion of their medication.
